and condition of the patient concurrent administration of other drugs counterindications and other parameters to be taken into account by the clinician the selected antibodies of this invention can be lyophilised for storage and reconstituted in a suitable carrier prior to use known lyophilisation and reconstitution techniques can be employed it will be appreciated by those skilled in the art that lyophilisation and reconstitution can lead to varying degrees of functional activity loss and that use levels may have to be adjusted upward to compensate in addition antibodies according to the present invention may be used for diagnostic purposes for example antibodies as herein described may be generated or raised against antigens which are specifically expressed during disease states or whose levels change during a given disease states for certain purposes such as diagnostic or tracing purposes labels may be added suitable labels include but are not limited to any of the following radioactive labels nmr spin labels and fluorescent labels means for the detection of the labels will be to familiar to those skilled in the art examples of suitable radioactive labels include technetium 99m 99m tc or iodine 123 123 i labels such as iodine 123 iodine 313 indium 111 fluorine 19 carbon 13 nitrogen 15 oxygen 17 gadolinium manganese or iron allow detection of the label using nmr labels such as 11c methionine and fdg are suitable for use in the technique of positron emission tomography descriptions of procedures and protocols for using pet are familiar to those skilled in the art a suitable fluorophore is gfp or a mutant thereof gfp and its mutants may be synthesised together with the antibodies of the present invention or target molecule by expression therewith as a fusion polypeptide according to methods.